HOME >> BIOLOGY >> NEWS
CSHL scientists successfully target tumor microenvironment to stop cancer growth

without harming normal blood vessels. This has significant clinical potential, particularly in fighting cancer re-growth after incomplete surgical resection or chemotherapy. The exciting news is that targeting such a minor population of the BM-derived tumor microenvironment has such a dramatic impact on tumor progression, said Mittal. The study makes clear that in addition to developing therapies that directly target cancer cells, it is also equally important to develop therapies that target critical non-cancer cells like EPCs.


'"/>

Contact: Dagnia Zeidlickis
Zeidlick@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
15-Jun-2007


Page: 1 2

Related biology news :

1. UK scientists working to help cut ID theft
2. Smithsonian scientists show differing patterns of rainforest biodiversity
3. Weizmann Institute scientists discover a control mechanism for metastasis
4. Cornell scientists link E. coli bacteria to Crohns disease
5. UCLA scientists produce functioning neurons from human embryonic stem cells
6. ASBMB taps 8 scientists and 1 politician for top awards
7. UF, French scientists seek test to detect gene doping in athletes
8. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
9. Forsyth scientists gain new understanding of adult stem cell regulation
10. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
11. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... ... a partnership to mobilize Colorado’s capital resources to support early-stage bioscience companies in ... but early-stage startups have struggled to find the funding they need to innovate ...
(Date:1/23/2020)... ... 2020 , ... GIOSTAR/HEAMGEN has developed and secured ... The red blood cells are made utilizing a bioreactor that permits the production ... replaces the need for a human blood donor. GIOSTAR/HEAMGEN mature red ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered ... brings together a consortium of over 100 partner organizations from industry, government, ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... , ... February 03, 2020 , ... ... Financial Services Firm Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry ... listed quarterly. Each Index illustrates the following statistics:, ...
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle ... to food and beverage manufactures within North America. Both Lifecycle and Midland have ... will allow each company to pool their collective resources and provide the industry ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, ... Kits . The new Salivary Total Human IgG Assay Kit exemplifies ... G in saliva, researchers can extend the accuracy and ease of use of ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the ... from strategic investors led by Halma plc , a FTSE 100 global ... Ventures, GII LLC, and WSJ Joshua Fund. A representative from Halma will join ...
Breaking Biology Technology:
Cached News: